# Evaluation of a New Thermostable Formulation of FLOLAN in Japanese Subjects

> **NCT02705807** · PHASE4 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 10 (actual)

## Conditions studied

- Cardiovascular Disease

## Interventions

- **DRUG:** FLOLAN injection with currently marketed diluent
- **DRUG:** FLOLAN injection with reformulated diluent

## Key facts

- **NCT ID:** NCT02705807
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05
- **Primary completion:** 2016-07
- **Final completion:** 2016-07
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2017-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02705807

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02705807, "Evaluation of a New Thermostable Formulation of FLOLAN in Japanese Subjects". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02705807. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*